PTIXW Projected Dividend Yield
Wt Exp 04/13/2025/Protagenic Therapeutics Inc ( NASDAQ : PTIXW )Protagenic Therapeutic is a development stage biopharmaceutical company focusing on the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. Co.'s proprietary compound, PT00114, is a synthetic form of Teneurin Carboxy-terminal Associated Peptide (TCAP), an endogenous brain signaling peptide that can dampen overactive stress responses. Additionally, Co. is engaged in the research and development of follow-on compounds in the TCAP family. Co. is performing clinical trials to obtain Food and Drug Administration approval and commercialization of its product. 20 YEAR PERFORMANCE RESULTS |
PTIXW Dividend History Detail PTIXW Dividend News PTIXW Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |